8 mars 2024 - Wegovy Approved by The FDA
Description:
The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.
Ajouté au bande de temps:
Date: